Description
Livagen is a synthetic bioregulatory peptide being studied for its role in regulating DNA structure and gene expression. Research indicates that Livagen may promote chromatin decondensation, potentially enhancing the expression of genes associated with cellular homeostasis. Its effects have been most extensively studied in lymphocytes, with investigations exploring its impact on immune system modulation and signaling in various tissue models, including cardiac, gastrointestinal, and neural systems. Additional studies are examining Livagen’s influence on nociceptive pathways and its relevance in pain signaling research.